SPG
ABBV icon

Strategic Planning Group’s AbbVie ABBV Stock Holding History

Strategic Planning Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,059
Closed -$7.35M – 78
2025
Q1 		$7.35M Sell
35,059
-263
-0.7% -$51.1K 1.44% 21
2024
Q4 		$6.28M Buy
35,322
+1,563
+5% +$287K 1.15% 26
2024
Q3 		$6.67M Buy
33,759
+1,583
+5% +$295K 1.31% 23
2024
Q2 		$5.52M Buy
32,176
+7,388
+30% +$1.22M 1.21% 27
2024
Q1 		$4.51M Buy
24,788
+3,080
+14% +$531K 1.13% 21
2023
Q4 		$3.36M Buy
+21,708
New +$3.16M 1.12% 24

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Strategic Planning Group's ABBV Position: Q2 2025 in Review

Strategic Planning Group sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 35,059 shares — an estimated $7.35M sold.

Strategic Planning Group first reported a position in ABBV in Q4 2023 and held it in 6 quarters. The position peaked at $7.35M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Strategic Planning Group reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Strategic Planning Group sold 35,059 AbbVie shares in Q2 2025, an estimated $7.35M.
  • Strategic Planning Group first reported a position in AbbVie in Q4 2023 and held it in 6 quarters.
  • Strategic Planning Group's AbbVie position peaked at $7.35M in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Strategic Planning Group's 13F filing for Q2 2025, filed 14 Jul 2025.